Belite Bio (BLTE) Current Assets (2021 - 2026)
Belite Bio's Current Assets came in at $501.6 million for Q2 2026, up 232.3% from $150.97 million a year earlier but down 3.9% from the prior quarter.
Powered by 
Analysis
Belite Bio (BLTE) Current Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, Belite Bio's Current Assets was $494.27 million, up 236.1% from FY2024.
- Current Assets has increased in each of the last four years, with a four-year compound annual growth rate of 130.8% (FY2021 to FY2025).
- Going back by year, Current Assets was $147.07 million in FY2024 (+63.5%), $89.94 million in FY2023 (+110.1%), $42.81 million in FY2022 (+145.6%) and $17.43 million in FY2021.
- The five-year range for quarterly Current Assets is $17.43 million (Q4 2021) to $521.86 million (Q1 2026).
- Year-over-year, Current Assets has increased for 11 consecutive quarters, with growth averaging 138.1% over the last eight quarters.
- The year-over-year growth in Current Assets has ranged between 18.4% (Q2 2023) and 236.1% (Q4 2025) over the last five years.
- Business Quant data shows BLTE's Current Assets at $521.86 million (Q1 2026), $494.27 million (Q4 2025) and $277.21 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Belite Bio | 6.53 Bn | 6.53 Bn | - | 501.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 501.60 Mn |
| Mar 31, 2026 | 521.86 Mn |
| Dec 31, 2025 | 494.27 Mn |
| Sep 30, 2025 | 277.21 Mn |
| Jun 30, 2025 | 150.97 Mn |
| Mar 31, 2025 | 159.29 Mn |
| Dec 31, 2024 | 147.07 Mn |
| Sep 30, 2024 | 111.27 Mn |
| Jun 30, 2024 | 113.86 Mn |
| Mar 31, 2024 | 96.47 Mn |
| Dec 31, 2023 | 89.94 Mn |
| Sep 30, 2023 | 56.14 Mn |
| Jun 30, 2023 | 59.14 Mn |
| Mar 31, 2023 | 38.42 Mn |
| Dec 31, 2022 | 42.81 Mn |
| Jun 30, 2022 | 49.93 Mn |
| Dec 31, 2021 | 17.43 Mn |
API Access
Belite Bio Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=BLTE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "BLTE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=BLTE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();